Delivery of CRISPR-Cas systems using phage-based vectors.

Area of Science:

• Microbiology
• Genetics
• Biotechnology

Background:

• Antimicrobial resistance (AMR) is a growing global health crisis, limiting treatment options for bacterial infections.
• CRISPR-Cas systems, prokaryotic adaptive immune mechanisms, can be engineered to induce bacterial cell death.
• Efficient delivery of CRISPR-Cas systems to target bacteria is crucial for therapeutic applications.

Purpose of the Study:

• To review the potential of engineered phages as delivery vectors for CRISPR-Cas systems.
• To discuss the production and application of phage-based vectors for antimicrobial therapy.
• To highlight advancements in phage engineering for improved CRISPR-Cas delivery.

Main Methods:

• Review of current literature on CRISPR-Cas systems and bacteriophage engineering.
• Analysis of phage-based vector production strategies.
• Discussion of recent progress in modifying phages for enhanced payload delivery.

Main Results:

• Engineered phages show promise as effective vectors for delivering CRISPR-Cas components into bacterial cells.
• Phage engineering techniques are advancing to overcome challenges in specificity and efficiency.
• Repurposed CRISPR-Cas systems delivered by phages represent a viable strategy against resistant bacteria.

Conclusions:

• Phage-based delivery of CRISPR-Cas systems is a promising avenue for combating antimicrobial resistance.
• Continued advancements in phage engineering are essential for realizing the full therapeutic potential of this approach.
• This strategy offers a novel alternative to conventional antibiotics, addressing the urgent need for new antimicrobial treatments.